Gene · 1452
Papers2,578
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 2,578
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Synthesis, biological evaluation and clinical trials of Cereblon-based PROTACs. | Commun Chem | 2025 | 40730655 | PubTator, text mining | PubMed |
| Casein kinase 1α essentially regulates thrombopoiesis by driving megakaryocyte maturation and cytoskeleton organization. | Blood | 2025 | 40729685 | PubTator, text mining | PubMed |
| Erratum: CK1α-targeting inhibits primary and metastatic colorectal cancer in vitro, ex vivo, in cell-line-derived and patient-derived tumor xenograft mice models. | Transl Cancer Res | 2025 | 40687247 | PubTator, text mining | PubMed |
| The contribution of native protein complexes to targeted protein degradation. | bioRxiv | 2025 | 40667143 | PubTator, text mining | PubMed |
| Phase I first-in-human dose escalation study of the oral casein kinase 1α and cyclin dependent kinase 7/9 inhibitor BTX A51 in advanced MDS and AML. | J Hematol Oncol | 2025 | 40665325 | PubTator, text mining | PubMed |
| FAM83A Promotes the Progression and Metastasis of Head and Neck Squamous Cell Carcinoma via PKM2-Mediated Aerobic Glycolysis. | FASEB J | 2025 | 40637278 | PubTator, text mining | PubMed |
| Gene expression inference based on graph neural networks using L1000 data. | Brief Bioinform | 2025 | 40505083 | PubTator, text mining | PubMed |
| Arctigenin-induced erythrocyte membrane remodelling is mediated through calcium influx, metabolic collapse, and casein kinase 1α. | Xenobiotica | 2025 | 40448583 | PubTator, text mining | PubMed |
| The ubiquitin ligase HUWE1 enhances WNT signaling by antagonizing destruction complex-mediated β-catenin degradation and through a mechanism independent of changes in β-catenin abundance. | PLoS Genet | 2025 | 40424469 | PubTator, text mining | PubMed |
| ProteinsPlus: a publicly available resource for protein structure mining. | Nucleic Acids Res | 2025 | 40326518 | PubTator, text mining | PubMed |
| Cellular parameters shaping pathways of targeted protein degradation. | Commun Biol | 2025 | 40316744 | PubTator, text mining | PubMed |
| Picolinic acid, a tryptophan metabolite, triggers cellular senescence by targeting NOS/p38 MAPK/CK1α/MLKL signaling and metabolic exhaustion in red blood cells. | Toxicol Res | 2025 | 40291116 | PubTator, text mining | PubMed |
| The role of CSNK1A1 and its de novo mutations in infantile spasms syndrome. | Hum Mol Genet | 2025 | 40156289 | PubTator, text mining | PubMed |
| Identification and functional characterization of key biomarkers in diffuse large B-cell lymphoma: emphasis on STYX as a prognostic marker and therapeutic target. | Hereditas | 2025 | 40128844 | PubTator, text mining | PubMed |
| Monoselective Histone Deacetylase 6 PROTAC Degrader Shows In Vivo Tractability. | J Med Chem | 2025 | 40063353 | PubTator, text mining | PubMed |
| ITGB1/FERMT1 mechanoactivation enhances CD44 characteristic stemness in oral squamous cell carcinoma via ubiquitin-dependent CK1α degradation. | Oncogene | 2025 | 40044983 | PubTator, text mining | PubMed |
| Molecular Glue-Design-Evaluator (MOLDE): An Advanced Method for In-Silico Molecular Glue Design. | ACS Omega | 2025 | 40028145 | PubTator, text mining | PubMed |
| Haploinsufficiency of miR-143 and miR-145 reveal targetable dependencies in resistant del(5q) myelodysplastic neoplasm. | Leukemia | 2025 | 40000845 | PubTator, text mining | PubMed |
| Wnt signaling inhibits casein kinase 1α activity by modulating its interaction with protein phosphatase 2A. | Cell Rep | 2025 | 39908140 | PubTator, text mining | PubMed |
| Development of Potent and Selective CK1α Molecular Glue Degraders. | J Med Chem | 2025 | 39873536 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1452/papers?page=5